These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18758417)

  • 21. Trends in perioperative outcome after hepatic resection: analysis of 1500 consecutive unselected cases over 20 years.
    Cescon M; Vetrone G; Grazi GL; Ramacciato G; Ercolani G; Ravaioli M; Del Gaudio M; Pinna AD
    Ann Surg; 2009 Jun; 249(6):995-1002. PubMed ID: 19474679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of proton pump inhibitors on benign anastomotic stricture formations after esophagectomy and gastric tube reconstruction: results from a randomized clinical trial.
    Johansson J; Oberg S; Wenner J; Zilling T; Johnsson F; von Holstein CS; Walther B
    Ann Surg; 2009 Nov; 250(5):667-73. PubMed ID: 19801933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics of patients with cirrhosis who are discharged from the hospital against medical advice.
    Myers RP; Shaheen AA; Hubbard JN; Kaplan GG
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):786-92. PubMed ID: 19345284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
    Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
    Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of diet on liver fibrosis and on response to interferon therapy in patients with HCV-related chronic hepatitis.
    Loguercio C; Federico A; Masarone M; Torella R; Blanco Cdel V; Persico M
    Am J Gastroenterol; 2008 Dec; 103(12):3159-66. PubMed ID: 18786125
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study.
    El-Serag HB; Fitzgerald S; Richardson P
    Am J Gastroenterol; 2009 Sep; 104(9):2161-7. PubMed ID: 19568229
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors associated with hepatic fibrosis in patients with chronic hepatitis C: a retrospective study of a large cohort of U.S. patients.
    Hu SX; Kyulo NL; Xia VW; Hillebrand DJ; Hu KQ
    J Clin Gastroenterol; 2009 Sep; 43(8):758-64. PubMed ID: 19238091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis.
    Sheng QS; Lang R; He Q; Yang YJ; Zhao DF; Chen DZ
    Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):46-9. PubMed ID: 19208514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Delayed endoscopy as a risk factor for in-hospital mortality in cirrhotic patients with acute variceal hemorrhage.
    Hsu YC; Chung CS; Tseng CH; Lin TL; Liou JM; Wu MS; Hu FC; Wang HP
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1294-9. PubMed ID: 19682197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased risk of exacerbating gastrointestinal disease among elderly patients following treatment with calcium channel blockers.
    Hamada A; Ishii J; Doi K; Hamada N; Miyazaki C; Hamada T; Ohwaki Y; Wada M; Nakashima K
    J Clin Pharm Ther; 2008 Dec; 33(6):619-24. PubMed ID: 19138239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease].
    Kwon JH; Park ST; Kim GD; You CR; Kim JD; Woo HY; Jang JW; Kim CW; Bae SH; Choi JY; Yoon SK
    Korean J Hepatol; 2009 Mar; 15(1):59-69. PubMed ID: 19346786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do proton-pump inhibitors increase the risk for nosocomial pneumonia in a medical intensive care unit?
    Beaulieu M; Williamson D; Sirois C; Lachaine J
    J Crit Care; 2008 Dec; 23(4):513-8. PubMed ID: 19056015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of laparoscopic splenectomy on portal hypertensive gastropathy in cirrhotic patients with portal hypertension.
    Anegawa G; Kawanaka H; Uehara H; Akahoshi T; Konishi K; Yoshida D; Kinjo N; Hashimoto N; Tomikawa M; Hashizume M; Maehara Y
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1554-8. PubMed ID: 19743999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for the detection of Barrett's esophagus in patients with erosive esophagitis.
    Modiano N; Gerson LB
    Gastrointest Endosc; 2009 May; 69(6):1014-20. PubMed ID: 19152902
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hepatitis A and B markers and vaccine indication in cirrhotic patients evaluated for liver transplantation in Spain.
    Aoufi S; Pascasio JM; Sousa JM; Sayago M; Ferrer MT; Gómez-Delgado E; De la Cruz MD; Alamo JM; Gómez-Bravo MA; Bernardos A; Márquez JL
    Transplant Proc; 2008 Nov; 40(9):2946-8. PubMed ID: 19010155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of the prescribing of potentially inappropriate medications at ambulatory care visits by elderly patients covered by the Taiwanese National Health Insurance program.
    Lai HY; Hwang SJ; Chen YC; Chen TJ; Lin MH; Chen LK
    Clin Ther; 2009 Aug; 31(8):1859-70. PubMed ID: 19808145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].
    Murcia J; Portilla J; Bedia M; Palazón JM; Sánchez-Payá J; Saiz de la Hoya P; Payá A; Boix V; Merino E; Reus S
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):206-12. PubMed ID: 19246126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Milder liver cirrhosis and loss of serum HBeAg do not imply lower risk for hepatocellular carcinoma development in HBV-related cirrhosis.
    Xu J; Shi J; Wang YP; Lin Y; Chen YX; Lu J; Zeng X; Xie WF
    Med Sci Monit; 2009 Jun; 15(6):CR274-9. PubMed ID: 19478697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors that predict survival in patients with cirrhosis considered for liver transplantation.
    Samada Suarez M; Hernández Perera JC; Ramos Robaina L; Barroso Márquez L; González Rapado L; Cepero Valdés M; Hernández Rivero H; Abdo Cuza A; Valdés AR; Pérez Bernal J; Bernardos A
    Transplant Proc; 2008 Nov; 40(9):2965-7. PubMed ID: 19010161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.